ASP AUTOMATIC ENDOSCOPE REPROCESSOR WITH PRINTER
Report
- Report Number
- 2084725-2009-00124
- Event Type
- Malfunction
- Date Received
- March 4, 2009
- Date of Event
- February 2, 2009
- Report Date
- February 2, 2009
- Manufacturer
- UNITROL/MINNTECH COR
- Product Code
- NVE
- PMA / PMN Number
- K832458
- Removal / Correction Number
- Z-0281-2009
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- OTHER
Narratives
CONCLUSION: THE CEC REPORTED THAT THE CUSTOMER WAS DISSATISFIED WITH THE STAINING OF THEIR CONNECTOR SETS AND DRIPPING. THE CEC MENTIONED THAT THIS IS USUAL FOR CIDEX OPA, BUT THE TUBING SETS EVEN AFTER TWO WEEKS OF USE WERE BLACK. THE CEC INSTRUCTED ON THE FOLLOWING: DILUTING THE ENZYMATIC TO THE PROPER CONCENTRATION WHEN WASHING SCOPES AND MAKING THE SINK SO AWARE OF HOW MANY PUMPS TO USE. THE CUSTOMERS ARE USING KLENZYME IN THE AER. THE CEC RECOMMENDED ENZOL. ALSO, THE CDC NOTICED THEY HAD A 6-MINUTE WASH CYCLE, CHANGED TO 1 MINUTE. THE CUSTOMER WAS ADVISED TO WATCH THE DRIPPING TO SEE IF IT IS ONLY FROM THE COLONOSCOPE OR THE GASTROSCOPE. THEY ARE USING THE MAJ 855 ATTACHMENT. ALSO, THE CEC ADVISED THAT THE BASINS SHOULD BE DRIED WITH A TOWEL AT THE END OF THE DAY AND LEFT OPEN. THE CEC NOTED THAT THE FACILITY IS AN EXCEPTIONALLY CLEAN DEPARTMENT. THE STAINING ON THE CONNECTOR SETS DID SEEM EXCESSIVE. AN ASP FIELD SERVICE ENGINEER (FSE) VISIT IS PENDING.
THE CUSTOMER ALLEGED THAT THERE WAS STAINING AND RESIDUE ON THE UNIT AND THEIR SCOPES. THE STAINING AND RESIDUE WERE IN ALL AREAS AFTER PROCESSING THE SCOPES IN THE UNIT WITH CIDEX OPA. THERE WERE NO REPORTS OF PHYSICAL COMPLAINTS. AN ASP CLINICAL EDUCATOR CONSULTANT (CEC) VISITED THE FACILITY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ASP AUTOMATIC ENDOSCOPE REPROCESSOR WITH PRINTER | AER EQUIPMENT | NVE | UNITROL/MINNTECH COR | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | CIDEX OPA |